| MeSH term | MeSH ID | Detail |
|---|---|---|
| Candidemia | D058387 | 2 associated lipids |
| AIDS-Related Opportunistic Infections | D017088 | 9 associated lipids |
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Xerostomia | D014987 | 6 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Urethritis | D014526 | 9 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Hemolysis | D006461 | 131 associated lipids |
| Gonorrhea | D006069 | 7 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Johnson EM et al. | Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations. | 1998 | Antimicrob. Agents Chemother. | pmid:9624486 |
| Groll AH et al. | Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits. | 1999 | Antimicrob. Agents Chemother. | pmid:10508025 |
| Ramaswamy M et al. | Species differences in the proportion of plasma lipoprotein lipid carried by high-density lipoproteins influence the distribution of free and liposomal nystatin in human, dog, and rat plasma. | 1999 | Antimicrob. Agents Chemother. | pmid:10348764 |
| Mehta RT et al. | Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis. | 1987 | Antimicrob. Agents Chemother. | pmid:3439798 |
| Mehta RT et al. | Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections. | 1987 | Antimicrob. Agents Chemother. | pmid:3439799 |
| Ostrosky-Zeichner L et al. | Differential antifungal activity of isomeric forms of nystatin. | 2001 | Antimicrob. Agents Chemother. | pmid:11557469 |
| Clements-Jewery S | Nystatin-induced potassium efflux from Saccharomyces cerevisiae measured by flame photometry: a potential bioassay approach. | 1976 | Antimicrob. Agents Chemother. | pmid:773299 |
| Hsuchen CC and Feingold DS | Selective membrane toxicity of the polyene antibiotics: studies on natural membranes. | 1973 | Antimicrob. Agents Chemother. | pmid:4586145 |
| Meletiadis J et al. | In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. | 2002 | Antimicrob. Agents Chemother. | pmid:11751112 |
| Hsuchen CC and Feingold DS | Selective membrane toxicity of the polyene antibiotics: studies on lecithin membrane models (liposomes). | 1973 | Antimicrob. Agents Chemother. | pmid:4758835 |
| Tevyashova AN et al. | Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group. | 2013 | Antimicrob. Agents Chemother. | pmid:23716057 |
| Badaracco G and Cassani G | Ribonucleic acid synthesis dependent on exogenous triphosphates in nystatin-treated cells of of Kluyveromyces latis. | 1976 | Antimicrob. Agents Chemother. | pmid:949173 |
| Segal E et al. | Susceptibility of Prototheca species to antifungal agents. | 1976 | Antimicrob. Agents Chemother. | pmid:984758 |
| Flattery AM et al. | New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents. | 1996 | Antimicrob. Agents Chemother. | pmid:8807048 |
| Brass C et al. | Variability of agar dilution-replicator method of yeast susceptibility testing. | 1979 | Antimicrob. Agents Chemother. | pmid:573098 |
| Sletta H et al. | Nystatin biosynthesis and transport: nysH and nysG genes encoding a putative ABC transporter system in Streptomyces noursei ATCC 11455 are required for efficient conversion of 10-deoxynystatin to nystatin. | 2005 | Antimicrob. Agents Chemother. | pmid:16251298 |
| Akiyama S et al. | Classification of polyene antibiotics according to their synergistic effect in combination with bleomycin A2 or fusidic acid. | 1980 | Antimicrob. Agents Chemother. | pmid:6160808 |
| Groll AH et al. | Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits. | 2003 | Antimicrob. Agents Chemother. | pmid:14638502 |
| Oakley KL et al. | Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole. | 1999 | Antimicrob. Agents Chemother. | pmid:10223948 |
| Cassidy SM et al. | Plasma lipoprotein distribution of liposomal nystatin is influenced by protein content of high-density lipoproteins. | 1998 | Antimicrob. Agents Chemother. | pmid:9687378 |